Chatdok

Name

Chatdok

Legal name

Chatdok GmbH

Website

https://chatdok.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Health AI Software

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

akta.pro secondary industries

Conversational AI Platforms (chat/voice bots, orchestration) (HDAAAFAC), Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH)

Keywords

• AI medical chatbot
• Digital therapeutics
• Health risk prediction
• Chronic care management
• Enterprise healthcare AI

Headquarters

HQ city

Düsseldorf

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Free Patient Platform (Current): Chatdok currently offers its services free of charge to patients. The platform is monetisation-free at present, with the company reserving the right to introduce fees in response to changing market conditions, significant changes in procurement costs, changes in sales tax, or procurement prices. Patients are notified in advance of any fee introduction and retain the right to terminate immediately.
2. Enterprise AI Agents & Licensing: Modular catalogue of production-grade AI agents sold to healthcare systems, insurers, and pharmaceutical companies. Includes virtual intake & triage agents, preventive risk stratification, chronic care outreach agents, post-discharge support, smart image analysis, and clinical trials/RWE support. Sold via discovery calls, demos, and custom co-development engagements.
3. Chatdok-Heart Digital Therapeutics: App-on-prescription digital therapeutic for cardiovascular conditions. Currently in final phase of clinical validation and MDR IIb approval. Will generate revenue upon regulatory approval through prescription/reimbursement channels.
4. Healthcare Provider Platform Fees: Chatdok facilitates telemedicine consultations between licensed physicians/MVZs and patients. While the platform currently does not charge patients, physicians pay for platform access or the service is funded through statutory/private health insurance billing (EBM/GOA) facilitated by the platform. Doctors issue electronic prescriptions and e-AUs through the platform.
5. AI Life Science Consulting: Consulting engagements helping healthcare and life science leaders identify high-value AI opportunities, craft responsible adoption roadmaps, and deliver custom co-developments. Custom co-development engagements for enterprise clients.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

Chatdok provides an AI-powered medical chatbot platform that delivers personalized, multimodal health information (text, voice, image) through specialty AI modules spanning Oncology, Cardiovascular, Dermatology, and Radiology. The company also offers Chatdok-Heart, a digital therapeutics app-on-prescription for chronic cardiovascular conditions (in final phase of clinical validation and MDR IIb approval), a Chronic Care Monitor for provider-side remote patient monitoring, and a modular catalogue of enterprise AI agents for health systems, insurers, and pharmaceutical companies. All products are built on its proprietary Cura 2.1 constellation framework and delivered under HIPAA and GDPR-compliant infrastructure.

Product overview

Chatdok is an AI-powered healthcare platform offering a portfolio of products centered on a core medical chatbot with multimodal AI capabilities. The main Chatdok platform provides a generative AI medical chatbot with specialized modules (Oncology AI, Cardiovascular AI, Dermatology AI, Radiology AI) powered by the Cura 2.1 model framework. Key products include Chatdok-Heart, a digital therapeutics app-on-prescription for cardiovascular conditions currently seeking MDR IIb approval, and the Chronic Care Monitor for provider-side remote patient monitoring. The platform also offers enterprise-grade AI agents for health systems, insurers, and pharma, and is developing a cardiac digital twin. All products are HIPAA and GDPR compliant.

Differentiator

Problem solved

Functional benefit

Brands

• Chatdok-Heart: Physician-led, AI-supported digital therapeutics for chronic cardiovascular conditions, with remote monitoring, patient empowerment, and proactive clinician oversight. A next-generation digital therapeutics app-on-prescription powered by generative AI and predictive analytics.
• Cura 2.1
• Chronic Care Monitor

Products and services

• Chatdok Medical Chatbot Platform Generative AI medical chatbot with multimodal capabilities (text, voice, image) and domain-specialized modules, designed for patients and healthcare providers. Delivers validated, guideline-based health information, symptom guidance, and health risk insights.
• Chatdok-Heart Digital Therapeutics Physician-led, AI-supported digital therapeutic for chronic cardiovascular conditions (heart failure, coronary artery disease) featuring remote monitoring, patient empowerment, adherence support, continuous monitoring, and proactive interventions. Designed to be prescribed and reimbursed upon MDR IIb approval.
• Chronic Care Monitor Provider-side remote patient monitoring platform with personalized care plan setup, comprehensive risk stratification, real-time trends and alerts, care optimization insights, continuous remote monitoring, and multimodal predictive analytics for cardiologists and chronic care teams.
• Health Risk Prediction Comprehensive, personalized risk predictions for the onset or recurrence of cardiovascular and oncology conditions, with actionable mitigation strategies, driven by AI analysis of lifestyle factors such as BMI, smoking, and alcohol use.
• AI Agents for Health Systems, Insurers and Pharma Modular catalogue of production-grade AI agents that automate and augment tasks across the care continuum using chats, voice, and images. Sold to health systems, insurers, and pharmaceutical companies via discovery calls, demos, and custom co-development engagements.
• AI Life Science Consulting Professional services offering that helps healthcare and life science leaders identify high-value AI opportunities, craft responsible adoption roadmaps, and deliver custom co-developments that turn vision into measurable outcomes.

Quantifiable outcome

• Chatdok-Heart is reducing cardiovascular events and risk factors in heart failure and coronary artery disease (currently in clinical validation phase)
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability11 records

Feature12 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Clinical and Academic Partners (Chatdok-Heart Digital Twin)coreStrategic or Co-development PartnerChatdok is in research and co-development with leading clinical and academic partners for the Chatdok-Heart Digital Twin — a next-generation personalized cardiac digital twin for interventional planning, multimodal predictive analytics, and management of comorbidities in chronic heart-failure patients. The exact names of these clinical and academic partners are not disclosed on the website.
• Pharmacies (Prescription Redemption)minorChannel Partner/ Reseller/ DistributorChatdok partners with local pharmacies to enable prescription redemption and medication delivery. Patients can redeem electronic prescriptions at cooperating pharmacies or mail-order pharmacies of their choice. Chatdok is not a pharmacy but facilitates the connection between patients and pharmacies.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ada Health: Berlin-based AI symptom assessment and health guidance platform used by consumers and health systems. Closest direct peer: comparable consumer-facing medical chatbot with enterprise B2B distribution and global multi-country reach.
• Infermedica: European (Poland-based) AI-driven symptom checker and triage platform sold to health systems and insurers. Comparable as a regulated medical AI chatbot with enterprise sales motion targeting payers and providers.
• Babylon Health: UK-headquartered AI health platform combining a medical chatbot, telehealth consultations, and population health tools for insurers and providers. Comparable across consumer chatbot, enterprise sales, and chronic care positioning.
• K Health: US-based AI-driven primary care and chronic condition management platform. Comparable in combining a free/consumer AI medical chatbot with paid virtual care and chronic care management offerings.
• Omada Health: US digital therapeutics company focused on chronic conditions (cardiometabolic, diabetes, hypertension) sold to payers and employers. Closest comparable for Chatdok-Heart as a regulated, condition-specific digital therapeutic.
• Wellframe: Digital care management and chronic care platform combining AI-supported patient engagement with remote monitoring for health plans and providers. Comparable to the Chronic Care Monitor offering.
• Biofourmis: AI-driven remote patient monitoring and digital therapeutics company focused on cardiology and chronic conditions. Comparable to Chatdok-Heart as a cardiovascular-focused AI RPM and DTx platform.
• Akili Interactive: FDA-cleared prescription digital therapeutics company. Comparable regulatory pathway (regulated software-as-a-medical-device) and prescription/reimbursement business model to Chatdok-Heart.

Regional players

• Doctolib: European leader in online doctor appointment booking and telehealth, dominant in Germany and France. Comparable as a European telehealth platform with physician workflow tools, but does not focus on AI medical chatbots or DTx.
• Zava: European online doctor and telemedicine service operating across the UK, Germany, France, and Ireland. Comparable European consumer telemedicine model with paid consultations, prescription delivery, and chronic care support.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/chatdok

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chatdok